Work

Management of type 2 diabetes: new and future developments in treatment

Year: 2011

Type: review

Source: The Lancet

DOI: 10.1016/s0140-6736(11)60207-9

Authors: Abd A Tahrani, Clifford J Bailey, Stefano Del Prato, Anthony H Barnett

Institutions: National Health Service, Heart of England NHS Foundation Trust, University of Birmingham, Aston University, University of Pisa

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly and Company, AstraZeneca, GlaxoSmithKline, Novartis, Roche, Sanofi, Takeda Pharmaceutical Company, National Institute for Health and Care Research, Novo Nordisk UK Research Foundation, Novo Nordisk, Servier, EMD Serono, Merck Sharp and Dohme

Award: Type 2 Diabetes Mellitus and its Microvascular Complications in South Asians in the UK: the Impact of Genes, Sleep and Metabolic Factors

OpenAlex ID: W2147187810

FWCI: 6.543

Cites: 129

Cited by: 546

Related to: 10